The FDA has cleared Dallen Medical Tensyn Plug for the treatment of hand and foot injuries.
3M to buy Ivera Medical
3M Cos. (NYSE:MMM) announced it has entered into an agreement to buy disinfectant-products maker Ivera.
Ivera’s lead product, the Curos I.V. port-connector cap, is used to help prevent catheter-related blood-stream infections, or CRBSIs. 3M said the product will complement its Tegaderm line of antimicrobial I.V. securement dressings.
Cutera expands stock buyback to $40M
FDA approves Sonoma’s FibuLock Nail for ankle fractures
The FDA has approved Sonoma Orthopedic Products’ FibuLock Nail device for the repair of ankle fractures.
Sonoma said FibuLock is designed to be a less invasive and more comfortable alternative to traditional surgical plates, which are screwed directly onto the bone through a large incision. In comparison, FibuLock Nails are inserted through a small incision directly into the bone canal.
Studies show Biotronik pacemakers safe for MRI use
German cardiac device-maker Biotronik announced that 2 studies have confirmed its ProMRI pacemaker systems are safe to use with certain MRI procedures.
The studies tracked 226 patients with ProMRI Evia/Entovis SR-T and DR-T pacemaker systems for up to 1 month after they received MRI scans of either the head or lower lumbar region. Neither study reported any serious adverse events.
GPO: Premier, Cook sign new purchasing contract
Group purchasing organization Premier Inc. (NSDQ:PINC) has signed a new pricing contract for Cook Medical urology products, Cook announced Wednesday.
FDA approves Pelvalon’s fecal incontinence device
FDA OKs 2nd phase for Presbia’s Flexivue Microlens pivotal
Pursuit Vascular lands $1.6m for ClearGuard device
Pursuit Vascular said it raise approximately $1.6 million in a debt and securities offering to a group of 33 unnamed investors.
Based in Maple Grove, Minn., Pursuit markets a device called ClearGuard that’s designed to kill bacteria and fungi in hemodialysis catheters. The product, an antimicrobial fluid lock, received FDA approval in late 2013.